A patients' organisation is taking the development of new drugs for Alzheimer's into its own hands in an effort to boost lower-cost drug discovery for the disease Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,